Endoscopic Severity Image Recognition to Advance Research and Training in Inflammatory Bowel Disease (EVEREST - IBD)
Observational · No treatment assigned · 1 site · Hull University Teaching Hospitals NHS Trust
Official record & contacts on ClinicalTrials.gov ↗
In plain English
What this trial is testing
Condition(s) listed: Inflammatory Bowel Disease 1. This is an observational study: researchers collect information (for example questionnaires, samples, or scans) but the study does not assign a treatment.
Who can join
- Ages 16 to 99
- Any sex
- Healthy volunteers accepted
Some of the main requirements, copied from the record:
- • Any adult patient aged 16 years or older who has consented to undergo endoscopic investigation where images are captured as part of routine clinical care.
There are also 2 reasons someone might not be able to join (exclusion criteria). Only the trial team can confirm whether you qualify.
What's involved
- About 4000 participants are expected to take part.
- Start date: 2021-09-17.
- Main results expected around 2031-09 (estimate from the record).
- 1 study site listed (1 marked recruiting) in United Kingdom.
Main thing being measured
- To develop and train a convolutional neural network to detect and characterise disease severity of inflammatory bowel disease during endoscopy (5 years)
In the researchers’ words
To develop and train a convolutional neural network to detect and characterize disease severity of inflammatory bowel disease during endoscopy
This is a short automatic summary built from the official record. A fuller plain-English card is coming; until then, please read the official record.
Questions to ask your doctor and the trial team
- Am I likely to qualify, given my health history?
- What would I have to do, and how often would I need to visit?
- Could I get a placebo? What happens to my current treatment?
- What are the possible risks and benefits?
- Are travel or other costs covered?
- What happens after the trial ends?
Official details
| Status | Recruiting |
|---|---|
| Phase | Observational |
| Study type | Observational |
| Conditions | Inflammatory Bowel Disease 1 |
| Lead sponsor | Hull University Teaching Hospitals NHS Trust |
| Collaborators | Wellcome/EPSRC Centre for Interventional and Surgical Sciences, University College London |
| Enrollment | 4000 (estimated) |
| Start date | 2021-09-17 |
| Primary completion (est.) | 2031-09 |
| First posted | 2021-04-30 |
| Last updated | 2024-11-15 |
| Official title | EVEREST - IBD: Endoscopic Severity Image Recognition to Advance Research and Training in Inflammatory Bowel Disease |
| ClinicalTrials.gov ID | NCT04867408 |
Interventions
- None listed
Full eligibility criteria (from the record)
Inclusion Criteria: * • Any adult patient aged 16 years or older who has consented to undergo endoscopic investigation where images are captured as part of routine clinical care. Exclusion Criteria: * • Any patient under the age of 16 * Patients who are unable to give informed consent to undergo endoscopic investigation or those who do not wish their pseudo-anonymised images to be used
Locations (1)
| Site | City | Country | Site status |
|---|---|---|---|
| Hull Royal Infirmary | Hull, East Yorkshire | United Kingdom | Recruiting |
For contacts at each site, use the official record.
Information only, not medical advice. Talk to your doctor and the trial team before making any decision about a clinical trial.